ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,051.41
-0.21%
US Tech 100
17,298.80
0.33%
Dow Jones
37,798.97
0.17%
Brent Oil
89.56
-0.35%
Bitcoin
63,843.96
0.66%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Altamira Therapeutics Ltd (CYTO) Quote

Altamira Therapeutics Ltd

Altamira Therapeutics Ltd (CYTO)

Cytophage Technologies Ltd
1.63
-0.03
(-1.81%)
At close: April 16 4:00PM
Delayed by 15 minutes
1.62
-0.04
( -2.41% )
After Hours: 7:14PM
Delayed by 15 minutes

Unlock more advanced trading tools

Join ADVFN today

Key stats and details

Current Price
1.62
Bid
1.60
Ask
1.65
Volume
56,496
1.54 Day's Range 1.73
1.54 52 Week Range 29.00
Market Cap
1.062M
Previous Close
1.66
Open
1.65
Last Trade
15
@
1.62
Last Trade Time
Financial Volume
$ 93,423
VWAP
1.6536
Average Volume (3m)
1,269,609
Shares Outstanding
349,500
Dividend Yield
-
PE Ratio
-0.04
Earnings Per Share (EPS)
-75.9
Revenue
306k
Net Profit
-26.53M

About Altamira Therapeutics Ltd

Altamira Therapeutics Ltd is dedicated to developing therapeutics that address unmet medical needs. It is active in RNA therapeutics, allergy and viral infections, and inner ear disorders. Its product Bentrio is a drug-free nasal spray for personal protection against airborne viruses and allergens. Altamira Therapeutics Ltd is dedicated to developing therapeutics that address unmet medical needs. It is active in RNA therapeutics, allergy and viral infections, and inner ear disorders. Its product Bentrio is a drug-free nasal spray for personal protection against airborne viruses and allergens.

Sector
Med, Dental, Hosp Eq-whsl
Industry
Med, Dental, Hosp Eq-whsl
Website
altamiratherapeutics.com
Headquarters
Basel, Che
Founded
1970
Altamira Therapeutics Ltd is listed in the Med, Dental, Hosp Eq-whsl sector of the NASDAQ with ticker CYTO. The last closing price for Altamira Therapeutics was $1.66. Over the last year, Altamira Therapeutics shares have traded in a share price range of $ 1.54 to $ 29.00.

Altamira Therapeutics currently has 349,500 shares outstanding. The market capitalization of Altamira Therapeutics is $1.06 million. Altamira Therapeutics has a price to earnings ratio (PE ratio) of -0.04.

CYTO Latest News

More News

Altamira Therapeutics Provides Business Update, Reports Full Year 2023 Financial Results

Hamilton, Bermuda, April 10, 2024 (GLOBE NEWSWIRE) -- Management to host conference call today, April 10, at 8.30 a.m. EDTRNA delivery business progressing with new collaborations, potential new...

April 10 2024
GlobeNewswire Inc.

Altamira Therapeutics to Host Full Year 2023 Financial Results and Business Update Call on April 10, 2024

Hamilton, Bermuda, April 04, 2024 (GLOBE NEWSWIRE) -- Altamira Therapeutics Ltd. ("Altamira" or the "Company") (Nasdaq: CYTO), a company providing nanoparticle-based technology for efficient RNA...

April 04 2024
GlobeNewswire Inc.

Altamira Therapeutics Announces Collaboration with Univercells Group on Nanoparticle-Delivered mRNA Vaccines

HAMILTON, BERMUDA, March 25, 2024 (GLOBE NEWSWIRE) -- Univercells to test proprietary mRNA vaccine delivered with Altamira’s SemaPhore™ nanoparticlesTargeting safer and accessible mRNA vaccines...

March 25 2024
GlobeNewswire Inc.

Altamira Therapeutics’ Peptide-Based Delivery Platform Shown to Enhance Potency of Commonly Used Gene Delivery Method as Published in Peer-Reviewed Journal

HAMILTON, BERMUDA, Feb. 07, 2024 (GLOBE NEWSWIRE) -- Independent peer-reviewed study shows enhanced cell transduction with adeno-associated virus (AAV) vectors, commonly used in gene therapy...

February 07 2024
GlobeNewswire Inc.

Altamira Therapeutics Files Second Provisional Patent Application for OligoPhore Nanoparticles Targeting Different KRAS Mutations in Cancer Treatment

HAMILTON, BERMUDA, Jan. 24, 2024 (GLOBE NEWSWIRE) -- Altamira’s polyKRASmut siRNA shown to knock down at least 65-91% of KRAS mutations in colorectal, non-small cell lung, and pancreatic cancer...

January 24 2024
GlobeNewswire Inc.

Form 424B4 - Prospectus [Rule 424(b)(4)]

January 22 2024
Edgar (US Regulatory)

Form EFFECT - Notice of Effectiveness

January 22 2024
Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

January 19 2024
Edgar (US Regulatory)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.3-15.6251.922.02991.541261721.848025CS
4-0.12-6.896551724141.743.491.5434721032.33985958CS
12-0.62-27.67857142862.243.491.5412696092.31734852CS
26-2.988-64.843754.60817.21.5486114566.7827102CS
52-20.98-92.831858407122.6291.5447427047.78540164CS
156-1170.38-99.861774744117215481.542710674190.98572441CS
260-1170.38-99.861774744117215481.542710674190.98572441CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
WISAWiSA Technologies Inc
$ 6.01
(243.43%)
199.41M
DYNTDynatronics Corp
$ 0.5602
(51.24%)
21.82M
JAGXJaguar Health Inc
$ 0.1778
(49.66%)
615.11M
ARRWArrowroot Acquisition Corporation
$ 18.00
(45.04%)
52.15k
PALIPalisade Bio Inc
$ 5.9299
(42.55%)
28.96M
PACBPacific Biosciences of California Inc
$ 1.40
(-50.62%)
59.82M
RVYLRYVYL Inc
$ 1.32
(-35.95%)
873.14k
KAVLKaival Brands Innovations Group Inc
$ 4.31
(-31.59%)
1.67M
PPBTPurple Biotech Ltd
$ 0.4121
(-29.36%)
1M
ATNF180 Life Sciences Corporation
$ 1.47
(-27.76%)
496.47k
JAGXJaguar Health Inc
$ 0.1778
(49.66%)
615.11M
WISAWiSA Technologies Inc
$ 6.01
(243.43%)
199.41M
SQQQProShares UltraPro Short QQQ
$ 11.44
(0.00%)
182.12M
TSLATesla Inc
$ 157.11
(-2.71%)
96.95M
NKLANikola Corporation
$ 0.6654
(1.81%)
82.96M

CYTO Discussion

View Posts
Monksdream Monksdream 2 weeks ago
CYTO under $3
👍️0
TheFinalCD TheFinalCD 3 weeks ago
$cyto 2.72 news https://healthstockshub.com/news/nasdaq/cyto/altamira-therapeutics-announces-collaboration-with-univercells-group-on-nanoparticle-delivered-mrna-vaccines

in @ 2.52
👍️0
Awl416 Awl416 3 weeks ago
PM pop
👍️0
Chuxster Chuxster 1 month ago
Bought at 1.71 and 1.72 respectively, yesterday.
👍️0
Monksdream Monksdream 2 months ago
And then a pr this morning
👍️0
Monksdream Monksdream 2 months ago
CYTO new 52 week low
👍️0
Monksdream Monksdream 2 months ago
CYTO new 52 week low
👍️0
Monksdream Monksdream 3 months ago
CYTO new 52 week low
👍️0
OffTheGrid OffTheGrid 4 months ago
Watching for entry
👍️0
CELTICAPPLE CELTICAPPLE 4 months ago
The dreaded reverse split.
👍️0
Invest-in-America Invest-in-America 4 months ago
CYTO: Whelp, 95%+ down right now in today's Pre-M, so, maybe it's time to "GRAB THOSE CHEAPIES"???
👍️0
1hot toddy 1hot toddy 4 months ago
sorry boys another rs tomorrow 20/1 then they will issue more shares as co has 34k. you guys should of sold instead of bought.

good luck ur going to need it. get ready for the ride down. hope im wrong 4 your sake
👍️0
hondaboost hondaboost 4 months ago
CYTO will do financing?
👍️0
luckydude777 luckydude777 4 months ago
Loving it!
👍️0
stockforce stockforce 4 months ago
They announced this webcast on Tuesday last week and didn’t release any other news after that. It surely sounds like some major updates will be announced today.
👍️0
Sunset Kid Sunset Kid 4 months ago
Best case scenerio, they release some good news before the webcast. That would be the logical way to play this if they truly have something big for investors. 12 tense hours to go, lol. Happy to be in regardless. Hope it goes over .60 in premarket. Good luck everyone (except shorty). God Bless us too!
👍️0
nathanial nathanial 4 months ago
Why hold a web call an hour before opening on Monday unless you have something really good to say? That's just crazy to put out and average web call on a Monday before the open with a nothing burger. They are doing this on purpose and want the whole trading day before them to react..
👍️ 1
buccaneer1961 buccaneer1961 4 months ago
I said...
👍️0
TheFinalCD TheFinalCD 4 months ago
.50 dip would help if the company had an X acct and tweeted something like the OTC stock pumps

in between their upcoming Investor call (which usually is a sell on CC day)

Altamira Therapeutics to Host Investor & Business Update Call on December 11th
December 05 2023 - 12:54PM



HAMILTON, BERMUDA--December 5, 2023--Altamira Therapeutics Ltd. ("Altamira" or the "Company") (Nasdaq: CYTO), a company dedicated to developing therapeutics that address important unmet medical needs, announced today that it will host an Investor and Business Update Call on Monday, December 11, 2023, 8:30 a.m. ET. The presentation will be available via teleconference or webcast with audio and presenter-controlled slides.
Webcast Access:

Date: Monday, December 11, 2023
Time: 8:30 a.m. Eastern Time (5:30 a.m. Pacific Time)
Webcast URL: https://edge.media-server.com/mmc/p/k7s8zdkg
👍️ 1
buccaneer1961 buccaneer1961 4 months ago
Nice to see squeeze to 2.00
👍️ 1
buccaneer1961 buccaneer1961 4 months ago
Dadgum that's high...shorts in trouble
👍️ 1
Sunset Kid Sunset Kid 4 months ago
'Cost To Borrow' The CTB represents the fee that short sellers must pay to borrow stock. According to The Street, the typical CTB fee hovers between 0.3% and 3%. A stock's CTB rises when short seller demand is high and falls when regular investor demand is high
👍️0
buccaneer1961 buccaneer1961 4 months ago
Ctb?? What is that?
👍️0
Penny_God Penny_God 4 months ago
337% CTB on this. Shorts are in hell.
👍️ 1
S-BEES-BUMBLEBEE S-BEES-BUMBLEBEE 4 months ago
$CYTO >>> KAAAABBBBOOOOOOOOOOOOOOOMMMMMMMMMM!!! $$$$$$$$$



$$$CYTO$$$
👍️0
da_stock_analyst da_stock_analyst 4 months ago
#CYTO 🔥 $1 tomorrow? Looking very bullish $CYTO
👍️0
buccaneer1961 buccaneer1961 4 months ago
Get lost organ....your a lying bag of pig internals
👍️0
halbroke1 halbroke1 4 months ago
CYTO $$$ HOPE TO SEE HKD TYPE MOVE HERE..
👍️0
da_stock_analyst da_stock_analyst 4 months ago
#CYTO 🔥 excited for tomorrow! Can move big $CYTO
👍️0
buccaneer1961 buccaneer1961 4 months ago
Is he saying reversal at .25? Trying to understand
👍️0
buccaneer1961 buccaneer1961 4 months ago
Video dosent post on android..in a nutshell where's the chart suggesting chart bouncing from and going to?
👍️0
buccaneer1961 buccaneer1961 4 months ago
Hopefully we get to .6 on the bounce chart ready for a bounce from .3? IL look at that video
👍️0
da_stock_analyst da_stock_analyst 4 months ago
#CYTO 🔥 reversal time soon! See price action! $CYTO
👍️0
vhgier vhgier 5 months ago
Stock will recover as more updates are released. Almost hit a buck the other day ~ still impressive to see in one trading day.
👍️0
OffTheGrid OffTheGrid 5 months ago
Toe dip .47
👍️0
da_stock_analyst da_stock_analyst 5 months ago
#CYTO 🔥 watch tomorrow! $CYTO
👍️0
Wallstveteran Wallstveteran 5 months ago
CYTO featured in this video...$1 soon ?
👍️0
Jess070283 Jess070283 5 months ago
What a beast!!!
👍️0
Michael TRed Michael TRed 5 months ago
Selling 1$
👍️0
S-BEES-BUMBLEBEE S-BEES-BUMBLEBEE 5 months ago
$CYTO >>> KAAAABBBBOOOOOOOOOOOOOOOMMMMMMMMMM!!! $$$$$$$$$
👍️0
TimeFades TimeFades 5 months ago
Massive day
👍️0
S-BEES-BUMBLEBEE S-BEES-BUMBLEBEE 5 months ago
$CYTO ~ Altamira Therapeutics Ltd
@0.6156
+0.3856 (+167.65%)
Volume: 112,809,400
Day Range: 0.2019 - 0.64
Last Trade Time: 3:36:23 PM EST


$$$CYTO$$$
👍️0
TheFinalCD TheFinalCD 5 months ago
$CYTO HERE WE GO
👍️0
Jess070283 Jess070283 5 months ago
$1+ soon IMO.
👍️0
S-BEES-BUMBLEBEE S-BEES-BUMBLEBEE 5 months ago
$CYTO >>> KABOOOOOOOOOOMMMMMMMMMMMMMMMM!!!!!!!!! $$$$$$$$$$


$NUWE next! ;)
👍️0
TheFinalCD TheFinalCD 5 months ago
Major Developments
5/4/2023, 8:05:01 AMApril amended note fully converted.
Did you find this tip useful?YesNo
4/13/2023, 9:10:54 AMOn April 13, 2023, the Company and FiveT IM entered into an amendment to the FiveT Loan (the “FiveT Loan Amendment”), which (i) amends to the conversion price of the FiveT Loan to a fixed price equal to the lower of (a) the mean daily trading volume weighted average price (“VWAP”) of the Company’s common shares, par value CHF 0.20 per share, on the Nasdaq Stock Market on the 20 trading days preceding the effective date of the FiveT Loan Amendment or (b) 90% of the VWAP on the effective date of the FiveT Loan Amendment
Did you find this tip useful?YesNo
Show 1 more entry
https://dilutiontracker.com/app/search/CYTO?a=dbb88c
👍️0
TheFinalCD TheFinalCD 5 months ago
UPGAP FILL MAYBE https://finviz.com/quote.ashx?t=CYTO&ty=c&ta=1&p=d
https://dilutiontracker.com/app/search/CYTO?a=dbb88c
👍️0
IVANj IVANj 5 months ago
Oooo baby
👍️0
Mikeyaces Mikeyaces 5 months ago
Lol
👍️0
Arnold25764 Arnold25764 5 months ago
Gonna drop low enough to fill the gap around .11?
👍️0

Your Recent History

NASDAQ
CYTO
Altamira Therapeutics
Delayed Upgrade Clock
ADVFN Logo

United States
Company
Business
Popular
Get The App

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved